Your session is about to expire
← Back to Search
Diabetes Care Intervention for Breast Cancer Patients
N/A
Recruiting
Led By Laura C Pinheiro, PhD, MPH
Research Sponsored by Weill Medical College of Cornell University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights
Study Summary
This trial is looking at whether having a nurse trained in diabetes care can help improve the care of patients with breast cancer and diabetes who are currently receiving chemotherapy treatment.
Who is the study for?
This trial is for adults over 18 with breast cancer and prediabetes or type 2 diabetes, who are about to start or currently receiving chemotherapy at Weill Cornell Medicine. It's not open to those with type 1 diabetes or patients in hospice care.Check my eligibility
What is being tested?
The study is testing if a nurse-practitioner specializing in diabetes can improve care for breast cancer patients with diabetes during chemotherapy. Participants will be split into two groups: one receives this specialized nursing support, the other does not.See study design
What are the potential side effects?
Since this trial involves standard care plus additional nursing support, there aren't new medical side effects expected from the intervention itself.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Data Collection Success Ratio
Intervention Completion Success Ratio
Number of in-person, virtual or phone contacts with the NP
+8 moreSecondary outcome measures
Change in Patient Self-report Responses of Diabetes Distress Scale Questionnaire
Change in Patient Self-report Responses of Diabetes Treatment Satisfaction Questionnaire
Change in Patient Self-report Responses of Neuropathy as Measured By the PRO-CTCAE Survey
+7 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Nurse-practitioner led intervention groupExperimental Treatment1 Intervention
A nurse practitioner (NP) who is trained in diabetes on the oncology team will help manage diabetes for breast cancer patients undergoing cancer treatments
Group II: Non-intervention (control) groupActive Control1 Intervention
Patient will not have access to the nurse practitioner led intervention.
Find a Location
Who is running the clinical trial?
Weill Medical College of Cornell UniversityLead Sponsor
1,055 Previous Clinical Trials
1,316,219 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,665 Previous Clinical Trials
40,925,778 Total Patients Enrolled
Laura C Pinheiro, PhD, MPHPrincipal InvestigatorAssistant Professor of Health Services Research in Medicine
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am currently receiving hospice care.I have pre-diabetes or type 2 diabetes, and may be on medication or have high blood sugar levels.I have Type 1 diabetes.I plan to undergo treatment before or after surgery at Weill Cornell Medicine.I am 18 years old or older.I have been recently diagnosed with invasive cancer.
Research Study Groups:
This trial has the following groups:- Group 1: Nurse-practitioner led intervention group
- Group 2: Non-intervention (control) group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there still available slots for participants in this research?
"According to data hosted on clinicaltrials.gov, the target recruitment goal of this medical experiment has been achieved and no additional candidates are being sought after. Initially posted in January 1st 2023, the trial was last updated on October 20th 2022. However, there are 3,954 other studies actively recruiting patients at present."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger